| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4270 | Protegenin A | Novel bacterial polyyne contributing to the antioomycete and plant-protective effects of P. protegens |
|
| DCC4271 | Prs-211375 | Novel selective CB2 agonist (CB2: 17.4 nM and CB1: 5585 nM) |
|
| DCC4272 | Pr-snf | Novel potent and selective inhibitor of SETD2 |
|
| DCC4273 | Prucalopride Hydrochloride | Selective 5-HT4 agonist |
|
| DCC4274 | Prx-07034 | Novel selective 5-HT6 receptor antagonist, enhancing cognition and memory and potently decreasing food intake and body weight in rodents |
|
| DCC4275 | Prx-08066 Maleate Featured | Novel potent and selective 5-HT2B receptor antagonist |
|
| DCC4276 | Ps1145 Dihydrochloride | Novel inhibitor of upstream IκB kinase (IKK), specifically inhibiting the IκB phosphorylation and degradation and the subsequent nuclear translocation of NF-κB |
|
| DCC4277 | Ps121912 | Highly potent and selective VDR-coactivator inhibitor |
|
| DCC4278 | Psammaplysene B | Naturally occurring inhibitor of FOXO1a nuclear export |
|
| DCC4279 | Psammaplysin F | Unique inhibitor of bacterial chromosomal partitioning, increasing the efficacy of bortezomib and sorafenib through regulation of stress granule formation |
|
| DCC4280 | Psb-1011 | Potent competitive antagonist and positive modulator of the P2X2 receptor with >100-fold selectivity versus P2X4, P2X7, and several investigated P2Y receptor subtypes (P2Y(2,4,6,12)) |
|
| DCC4281 | Psb-10129 | Positive modulator of ATP effects at P2X2 receptors |
|
| DCC4282 | Psb-10211 | Potent competitive antagonist and positive modulator of the P2X2 receptor |
|
| DCC4283 | Psb-12105 | Novel fluorescent-labeled selective adenosine A2B receptor antagonist |
|
| DCC4284 | Psb-1410 | Highly potent, selective, competitive, and reversible inhibitor of monoamine oxidase B (MAO-B) |
|
| DCC4285 | Psb-1434 Featured | Highly potent, selective, competitive, and reversible inhibitor of monoamine oxidase B (MAO-B) |
|
| DCC4286 | Psb-1491 Featured | Highly potent, selective, competitive, and reversible inhibitor of monoamine oxidase B (MAO-B) |
|
| DCC4287 | Psb-16131 | Novel potent Lp1NTPDase inhibitor |
|
| DCC4288 | Psb-16133 | Novel Potent and Selective Antagonist for the UTP-Activated P2Y4 Receptor |
|
| DCC4289 | Psb-16282 | Novel Potent Agonist of the Orphan G Protein-Coupled Receptor GPR17 (EC 50 12 nM) |
|
| DCC4290 | Psb-16434 | Novel potent and selective agonist of the orphan G protein-coupled receptor 84 (GPR84) |
|
| DCC4291 | Psb-18332 | Fluorescent Probe for Ecto-5'--nucleotidase (CD73) |
|
| DCC4292 | Psb-18422 | Novel Potent Agonist of the Orphan G Protein-Coupled Receptor GPR17 (EC 50 27.9 nM) |
|
| DCC4293 | Psb-18484 | Novel Potent Agonist of the Orphan G Protein-Coupled Receptor GPR17 (EC 50 32.1 nM) |
|
| DCC4294 | Psb-19416 | Fluorescent Probe for Ecto-5'--nucleotidase (CD73) |
|
| DCC4295 | Psb-6426 | The first potent and selective inhibitor of human nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) |
|
| DCC4296 | Psb-kd107 | Novel Agonist of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18, being selective versus the CB-sensitive receptors CB1, CB2, and GPR55 |
|
| DCC4297 | Psb-kd477 | Novel Agonist of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18, being selective versus the CB-sensitive receptors CB1, CB2, and GPR55 |
|
| DCC4298 | psb-sb-1203 | Potent GPR55 antagonist |
|
| DCC4299 | psb-sb-489 | Novel Selective, competitive GPR55 antagonist |
|
